AUTOCYTE PREP AUTOMATED SAMPLE PREPARATION SYSTEM PMA FILED JUNE 11, FIRM SAYS IN INITIAL PUBLIC OFFERING; SCREEN PMA SLATED FOR LATE `97, EARLY `98
This article was originally published in The Gray Sheet
Executive Summary
Autocyte plans to use a portion of proceeds from its $36.6 mil. initial public offering to nearly triple the size of its sales and marketing organization in anticipation of U.S. and international launches of the Prep automated cervical specimen preparation device and Screen automated slide screening and interpretation system, the Burlington, North Carolina-based firm says in a June 27 preliminary prospectus for the IPO.